SCHEMBL6233733

SCHEMBL6233733

COc1[c]cc(C)c([N+](=O)[O-])c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
TSHR P16473 5/20 0.41
CYP3A4 P08684 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALOX15 P16050 1/20 0.38
PRKDC P78527 1/20 0.38
TPMT P51580 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GPR35 Q9HC97 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28383967 0.86 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4TDP1RECQL
SCHEMBL3196901 0.84 ALDH1A1 (0.47) ALDH1A1TSHRCYP3A4TDP1HSD17B10
SCHEMBL6816414 0.82
SCHEMBL17339128 0.77 TDP1 (0.42) ALDH1A1TSHRCYP3A4TDP1HSD17B10
SCHEMBL15063757 0.77 TSHR (0.46) ALDH1A1TSHRCYP3A4TDP1RECQL
SCHEMBL8426114 0.76 VCAM1 (0.40) ALDH1A1TSHRCYP3A4TDP1HSD17B10
SCHEMBL1891926 0.76 TSHR (0.44) ALDH1A1TSHRCYP3A4TDP1RECQL
SCHEMBL10326054 0.75 ALDH1A1 (0.57) ALDH1A1TSHRCYP3A4TDP1HSD17B10
SCHEMBL20584089 0.74 CYP1A2 (0.47) ALDH1A1TSHRCYP3A4TDP1RECQL
SCHEMBL6152635 0.74 TSHR (0.43) ALDH1A1TSHRCYP3A4TDP1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993441-B1 INHIBITORS OF p38 VERTEX PHARMA (US) 2005-06-01 EP disclosed
US-6093742-A TREATMENT OF INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, DESTRUCTIVE BONE DISORDERS, PROLIFERATIVE DISORDERS, INFECTIOUS DISEASES, VIRAL DISEASE, AND NEURODEGENERATIVE DISEASES VERTEX PHARMACEUTICALS, INC. (US) 2000-07-25 US disclosed
EP-0993441-A1 INHIBITORS OF p38 Vertex Pharmaceuticals Incorporated (US) 2000-04-19 EP disclosed
WO-1999000357-A1 INHIBITORS OF p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 1999-01-07 WO disclosed